PT-141 10mg

PT-141 (10 mg), also known as bremelanotide, is a synthetic cyclic heptapeptide developed using Melanotan II–based pharmaceutical scaffolding and refined for laboratory research applications. The PT-141 peptide has an approximate molecular weight of 1,025 Da and exhibits selective affinity toward melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptor subtypes, making it a relevant compound for studies of hypothalamic neuropeptide signaling.

The peptide is supplied as a high-purity lyophilized powder in a sealed research-grade vial to support accurate handling and reproducible preparation. Its cyclic structure enables focused investigation of central melanocortin pathways, particularly those associated with hypothalamic regulatory centers involved in neural and hormonal signaling.

Current research use includes controlled experimental models examining:

• Hypothalamic signaling dynamics
• Melanocortin receptor subtype selectivity
• Central neuroendocrine regulation

All research is conducted strictly in non-clinical laboratory environments.

• High-purity PT-141 peptide formulated for laboratory research
• Supplied as a 10 mg lyophilized powder for precise reconstitution
• Cyclic peptide structure supporting experimental stability
• Demonstrates selective targeting of MC3R and MC4R receptor subtypes
• Supports investigation of hypothalamic neuropeptide signaling
• Formulated for G-protein coupled receptor (GPCR) research applications
• Packaged in sealed vials to maintain integrity and traceability
• Commonly selected by laboratories that buy PT-141 peptide
• For laboratory research use only.

PT-141 is being investigated for its role in melanocortin-mediated GPCR signaling within the central nervous system, with particular focus on hypothalamic regulatory regions. Laboratory studies examine how this peptide interacts with MC3R and MC4R receptor pathways to influence centrally mediated signaling processes.

Research applications commonly include:

• Studies of melanocortin receptor subtype selectivity
• Evaluation of hypothalamic neuropeptide signaling pathways
• Investigation of G-protein coupled receptor (GPCR) activation
• Comparative analysis of receptor-selective melanocortin compounds

These investigations are designed to generate structured laboratory data that inform peptide signaling behavior and experimental design.

Published research describes a range of experimental dosing approaches for PT-141, depending on the study model and objectives. Laboratory protocols commonly report:

• Microgram- to milligram-equivalent ranges
• Administration under controlled experimental conditions
• Model-specific timing and exposure parameters

Observed effects are documented as measurable changes in central signaling activity, neuroendocrine markers, or hypothalamic response patterns, rather than therapeutic outcomes. Researchers who order PT-141 peptide use these findings to refine study parameters, compare receptor-selective compounds, and assess reproducibility across experimental systems.

All dosing information is presented strictly within a research context and is not intended for human or veterinary use.

In its lyophilized state, store PT-141 at –20 °C or below. Ensure it is protected from light and moisture to preserve peptide integrity. After reconstitution, researchers can follow these steps:

• Prepare using sterile laboratory techniques

• Store according to institutional research protocols
• Minimize repeated freeze–thaw cycles

Handle the PT-141 peptide only in controlled research environments. Always remember to follow standard laboratory safety and documentation procedures

References

https://pubmed.ncbi.nlm.nih.gov/12851303/

https://onlinelibrary.wiley.com/doi/full/10.1002/j.1939-4640.2004.tb02842.x

https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/

https://pmc.ncbi.nlm.nih.gov/articles/PMC12322139/

https://www.sciencedirect.com/science/article/pii/S0925443917301072

https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.